Suppr超能文献

内皮素ETA受体在人脑血管平滑肌细胞中的表达

Endothelin ETA receptor expression in human cerebrovascular smooth muscle cells.

作者信息

Yu J C, Pickard J D, Davenport A P

机构信息

Clinical Pharmacology Unit, University of Cambridge, Addenbrooke's Hospital.

出版信息

Br J Pharmacol. 1995 Nov;116(5):2441-6. doi: 10.1111/j.1476-5381.1995.tb15093.x.

Abstract
  1. Endothelin (ET) has been implicated in cerebrovasospasm for example, following subarachnoid haemorrhage, and blocking the interaction of ET with its receptors on cerebral vessels, may be of therapeutic benefit. The aim of our study was to characterize endothelin receptor sub-types on medial smooth muscle cells of human cerebral vessels. Cultures of vascular smooth muscle cells were explanted from human cerebral resistance vessels and characterized as human brain smooth muscle cells (HBSMCs). 2. Over a 48 h incubation period, HBSMC cultures secreted comparable levels of immunoreactive (IR) big endothelin-1 (big ET-1) and IR endothelin (ET): 12.7 +/- 10.3 and 8.3 +/- 5.6 pmol/10(6) cells, respectively (mean +/- s.e. mean from three different individuals), into the culture medium. 3. Total RNA was extracted from cultures of human brain smooth muscle cells. Reverse-transcriptase polymerase chain reaction (RI-PCR) assays and subsequent product separation by agarose gel electrophoresis revealed single bands corresponding to the expected product sizes encoding cDNA for ETA (299 base pairs) and ETB (428 base pairs) (n = 3 different cultures). 4. Autoradiography demonstrated the presence of specific binding sites for [125I]-ET-1 which labels all ET receptors, and [125I]-PD151242, an ETA subtype-selective antagonist which exclusively labels ETA receptors, but no specific-binding was detected using ETB subtype-selective [125I]-BQ3020 (n = 3 different cultures, in duplicate). 5. In saturation binding assays, [123I]-ET-1 bound with high affinity: KD = 0.8 +/- 0.1 nM and Bmax = 690 +/- 108 fmol mg-1. A one-site fit was preferred and Hill slopes were close to unity over the concentration range (10(-12) to 10(-8) M). [125I]-PD151242 also bound with similar affinity: KD = 0.4 +/- 0.1 nM and Bmax = 388 +/- 68 fmol mg-1 (mean +/- s.e. mean, n = 3 different cultures). Again, a one-site fit was preferred and Hill slopes were close to unity over the concentration range. Unlabelled PD151242 competed for the binding of [125I]-ET-1 monophasically and analysis of the competition curves indicated that a one-site fit was preferred over a two-site model, implying that the cultures express mainly ETA receptors. 6. Although messenger RNA encoding both ETA and ETB receptors was detected, autoradiographical analysis, as well as binding studies indicate that human cultured brain smooth muscle cells express only ETA receptor protein. Antagonism of this sub-type may be necessary to block the actions of ET-1 in the human cerebral resistance vessels in the vasospasm observed subsequent to subarachnoid haemorrhage.
摘要
  1. 例如,内皮素(ET)与蛛网膜下腔出血后的脑血管痉挛有关,阻断ET与其在脑血管上的受体相互作用可能具有治疗益处。我们研究的目的是鉴定人脑血管中膜平滑肌细胞上的内皮素受体亚型。从人脑阻力血管中分离出血管平滑肌细胞培养物,并将其鉴定为人脑平滑肌细胞(HBSMCs)。2. 在48小时的孵育期内,HBSMC培养物分泌出相当水平的免疫反应性(IR)大内皮素-1(big ET-1)和IR内皮素(ET):分别为12.7±10.3和8.3±5.6 pmol/10⁶细胞(平均值±标准误,来自三个不同个体),进入培养基。3. 从人脑平滑肌细胞培养物中提取总RNA。逆转录聚合酶链反应(RT-PCR)分析及随后通过琼脂糖凝胶电泳进行的产物分离显示,对应于编码ETA(299个碱基对)和ETB(428个碱基对)cDNA预期产物大小的单条带(n = 3种不同培养物)。4. 放射自显影显示存在针对标记所有ET受体的[¹²⁵I]-ET-1以及仅标记ETA受体的ETA亚型选择性拮抗剂[¹²⁵I]-PD151242的特异性结合位点,但使用ETB亚型选择性[¹²⁵I]-BQ3020未检测到特异性结合(n = 3种不同培养物,一式两份)。5. 在饱和结合试验中,[¹²³I]-ET-1以高亲和力结合:KD = 0.8±0.1 nM,Bmax = 690±108 fmol mg⁻¹。在浓度范围(10⁻¹²至10⁻⁸ M)内,单点拟合更佳且希尔斜率接近1。[¹²⁵I]-PD151242也以类似亲和力结合:KD = 0.4±0.1 nM,Bmax = 388±68 fmol mg⁻¹(平均值±标准误,n = 3种不同培养物)。同样,单点拟合更佳且在浓度范围内希尔斜率接近1。未标记的PD151242对[¹²⁵I]-ET-1的结合进行单相竞争,竞争曲线分析表明单点拟合优于双点模型,这意味着培养物主要表达ETA受体。6. 尽管检测到编码ETA和ETB受体的信使RNA,但放射自显影分析以及结合研究表明,人培养的脑平滑肌细胞仅表达ETA受体蛋白。在蛛网膜下腔出血后观察到的血管痉挛中,拮抗该亚型可能是阻断ET-1在人脑阻力血管中作用所必需的。
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8398/1909054/4cf81314c599/brjpharm00178-0117-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验